The timeline for a regional deal is end of FY24 or even July from memory, so I don’t understand why you would quote that now.
It is not unreasonable to assume any deal is contingent on the FDA stage 2 confirmation, in fact it makes perfect sense.
General OA media and info, page-581
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.010(4.35%) |
Mkt cap ! $83.95M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.3¢ | $98.72K | 418.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 105806 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 24542 | 5 |
View Market Depth
| Last trade - 14.38pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
0.010 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 23.5¢ | 24.0¢ | 23.5¢ | 63626 | ||
| Last updated 14.41pm 14/06/2024 ? | |||||
| PAR (ASX) Chart |